DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee.
about
Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior.Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonistsThe importance of somatic symptoms in depression in primary careCo-variation of depressive mood and locomotor dynamics evaluated by ecological momentary assessment in healthy humans.Psychological distress and quality of life in older persons: relative contributions of fixed and modifiable risk factorsPatterns of morning and evening fatigue among adults with HIV/AIDS.Somatic symptoms in depression.Core symptoms of major depressive disorder: relevance to diagnosis and treatment.The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project.A novel strategy for dissecting goal-directed action and arousal components of motivated behavior with a progressive hold-down taskDifferential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.Depression in adolescents and young adults with cancer.Physiological Sleep Propensity Might Be Unaffected by Significant Variations in Self-Reported Well-Being, Activity, and MoodCollege students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severityQualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2).Acute stress induces selective alterations in cost/benefit decision-making.Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trialsIPS multicentric study: Functional somatic symptoms in depression.The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Latvian family physicians' experience diagnosing depression in somatically presenting depression patients: A qualitative study.Perturbations in Effort-Related Decision-Making Driven by Acute Stress and Corticotropin-Releasing Factor.Why treat depression differently from other medical problems?Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.
P2860
Q30490176-02133970-9C96-4D00-89ED-A9AAC9B93997Q33375926-12B620D9-2E5C-449E-8836-04AB01875132Q33591276-A51CC4BB-6830-40CE-9A34-572F92E823D5Q33872174-F4E69D20-A6D1-475E-9FD2-01857C677E4EQ33928331-ACAD34E9-46EB-49C8-8A22-8650D291945CQ34994937-9A42E2D9-D418-47C3-9419-FEFCA88FBE29Q35011082-FB524E5E-E372-42FD-A586-B5F196F8CCACQ35107024-55EB3BE2-B0B8-437F-BEC6-89A7E67743D3Q35236704-2B7BC354-08FE-45DE-B1AC-3079CCC4D82AQ35237009-671C9905-9A42-40CB-B135-DF8A1261DDB1Q35608939-4A29CD43-E0B2-49A0-9410-5E70B1C257FDQ35672560-A913602A-AB9D-4006-BB9E-56B40348441BQ35706890-827F6096-1C2B-4A91-A2AB-124BF0D441CEQ35899456-6EA6718A-D5C3-41CB-AB1C-075311F7FA3BQ35947315-0CFC16E7-D428-45FD-A025-9343D0596AEAQ35964474-7B5689B6-7C85-4BA9-9904-01AEC22388F7Q36073604-D8EB0346-6CF4-4B0F-8D58-3637B70F488EQ36174063-997C2063-25A6-456D-AE80-11A0E750E137Q36380157-D5C30554-1464-45DF-936D-D69688D34544Q36615486-6BEAD9F0-8CEB-4935-82B4-E16A0EF0042EQ36622049-271D71E2-29A2-4EC5-873E-B3A2FDF45D28Q37405474-2D7E50B8-1FCF-4290-98C5-0F0A69007029Q38836831-D3434322-6E48-44E1-8C7D-27A1D619A114Q40454801-DAEB62E9-9267-4703-9C28-462BF5AB6CB4Q42152528-3A90C8B2-96C2-49A4-B2BA-846E57985215Q42875561-E390E1B0-6FA3-4E6C-A410-88E9AE3D9BB8Q43180394-AA811DA8-56FD-457F-BB4A-0A0E7769907BQ52599712-1AD1D50A-81D5-472B-BD5A-680F965B7BF6Q55132660-BF44FD95-B245-4D65-91DA-F46F46739DD6
P2860
DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@en
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@nl
type
label
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@en
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@nl
prefLabel
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@en
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@nl
P2093
P1476
DEPRES II (Depression Research ...... ty. DEPRES Steering Committee.
@en
P2093
P304
P577
1999-05-01T00:00:00Z